PTGX vs SWKS · rev $269.8M vs P/E 29, rev $4.09B
Protagonist Therapeutics Inc (PTGX) versus Skyworks Solutions Inc (SWKS) — a side-by-side from cached financials, not a winner call.
Protagonist Therapeutics Inc (PTGX) is a biotechnology company listed on NASDAQ.
Skyworks Solutions Inc (SWKS) is a semiconductors company listed on NASDAQ.
Latest reported PTGX revenue for 2026-06-30 was $269.8M. Net income was $166.6M. PTGX currently screens at market cap $7.25B.
Latest reported SWKS revenue for 2025-10-03 was $4.09B. Net income was $477.1M. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
PTGX currently screens at market cap $7.25B. SWKS currently screens at market cap $10.44B and trailing P/E 28.9.
Not investment advice. Open the PTGX and SWKS stock pages for the full models.
Not investment advice.